Sign in
4

Changes in Ownership

Raphael Pharmaceutical Inc. Filed Acc 0001213900-26-040590

Chief Technology Officer acquired 350,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Louria Hayon Igal · Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-20 Option exercise : show line 1 in the form +350,000 $0.01 $3,500 1,349,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-20 Option exercise : show line 2 in the form Warrants to purchase Common Stock −350,000 0 D
Loading xslF345X06/ownership.xml…